BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23112346)

  • 1. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.
    Mazharian A; Wang YJ; Mori J; Bem D; Finney B; Heising S; Gissen P; White JG; Berndt MC; Gardiner EE; Nieswandt B; Douglas MR; Campbell RD; Watson SP; Senis YA
    Sci Signal; 2012 Oct; 5(248):ra78. PubMed ID: 23112346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
    Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
    Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
    Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
    Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice.
    Mazharian A; Maître B; Bornert A; Hennequin D; Lourenco-Rodrigues M; Geer MJ; Smith CW; Heising S; Walter M; Montel F; Walker LSK; de la Salle H; Watson SP; Gachet C; Senis YA
    Blood Adv; 2023 Jan; 7(1):46-59. PubMed ID: 36269841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
    Vögtle T; Sharma S; Mori J; Nagy Z; Semeniak D; Scandola C; Geer MJ; Smith CW; Lane J; Pollack S; Lassila R; Jouppila A; Barr AJ; Ogg DJ; Howard TD; McMiken HJ; Warwicker J; Geh C; Rowlinson R; Abbott WM; Eckly A; Schulze H; Wright GJ; Mazharian A; Fütterer K; Rajesh S; Douglas MR; Senis YA
    Elife; 2019 Aug; 8():. PubMed ID: 31436532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets.
    Smith CW; Thomas SG; Raslan Z; Patel P; Byrne M; Lordkipanidzé M; Bem D; Meyaard L; Senis YA; Watson SP; Mazharian A
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):823-835. PubMed ID: 28336561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPVI signaling is compromised in newly formed platelets after acute thrombocytopenia in mice.
    Gupta S; Cherpokova D; Spindler M; Morowski M; Bender M; Nieswandt B
    Blood; 2018 Mar; 131(10):1106-1110. PubMed ID: 29295843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
    Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
    Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G6b-B regulates an essential step in megakaryocyte maturation.
    Becker IC; Nagy Z; Manukjan G; Haffner-Luntzer M; Englert M; Heib T; Vögtle T; Gross C; Bharti R; Dietrich S; Mott K; Heck J; Stegmaier S; Baranowsky A; Schinke T; Schlegel N; Heckel T; Stegner D; Pleines I; Ignatius A; Schulze H; Nieswandt B
    Blood Adv; 2022 May; 6(10):3155-3161. PubMed ID: 35134123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B.
    Soriano Jerez EM; Gibbins JM; Hughes CE
    Platelets; 2021 Aug; 32(6):761-769. PubMed ID: 33646086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.
    Mori J; Nagy Z; Di Nunzio G; Smith CW; Geer MJ; Al Ghaithi R; van Geffen JP; Heising S; Boothman L; Tullemans BME; Correia JN; Tee L; Kuijpers MJE; Harrison P; Heemskerk JWM; Jarvis GE; Tarakhovsky A; Weiss A; Mazharian A; Senis YA
    Blood; 2018 Mar; 131(10):1122-1144. PubMed ID: 29301754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD.
    Léon C; Evert K; Dombrowski F; Pertuy F; Eckly A; Laeuffer P; Gachet C; Greinacher A
    Blood; 2012 Apr; 119(14):3333-41. PubMed ID: 22234693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein.
    Senis YA; Tomlinson MG; García A; Dumon S; Heath VL; Herbert J; Cobbold SP; Spalton JC; Ayman S; Antrobus R; Zitzmann N; Bicknell R; Frampton J; Authi KS; Martin A; Wakelam MJ; Watson SP
    Mol Cell Proteomics; 2007 Mar; 6(3):548-64. PubMed ID: 17186946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model.
    Poujol C; Ware J; Nieswandt B; Nurden AT; Nurden P
    Exp Hematol; 2002 Apr; 30(4):352-60. PubMed ID: 11937271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPIbα-filamin A interaction regulates megakaryocyte localization and budding during platelet biogenesis.
    Ellis ML; Terreaux A; Alwis I; Smythe R; Perdomo J; Eckly A; Cranmer SL; Passam FH; Maclean J; Schoenwaelder SM; Ruggeri ZM; Lanza F; Taoudi S; Yuan Y; Jackson SP
    Blood; 2024 Jan; 143(4):342-356. PubMed ID: 37922495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly.
    Jurak Begonja A; Hoffmeister KM; Hartwig JH; Falet H
    Blood; 2011 Aug; 118(8):2285-95. PubMed ID: 21652675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of the collagen receptors leukocyte-associated immunoglobulin-like receptor-1 and glycoprotein VI on a subset of megakaryoblasts.
    Steevels TA; Westerlaken GH; Tijssen MR; Coffer PJ; Lenting PJ; Akkerman JW; Meyaard L
    Haematologica; 2010 Dec; 95(12):2005-12. PubMed ID: 20713462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
    Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
    Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.